TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

ALX Oncology to Present at Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Alx Oncology Holdings Inc.
ALX Oncology to Present at Upcoming Investor Conferences

ALX Oncology will participate in two healthcare conferences in November and December 2025, presenting their ongoing clinical-stage cancer therapies, including lead candidate evorpacept and new pipeline candidate ALX2004.

Insights
EEM   negative

Higher expense ratio (0.72%), less diversified with concentrated holdings, lower dividend yield (2.1%), and lower historical returns


ALXO   positive

Company is presenting at major healthcare conferences, highlighting ongoing clinical trials and pipeline progress in cancer therapies, indicating active research and development